Global Certificate in Drug Discovery: Future-Ready Strategies
-- ViewingNowThe Global Certificate in Drug Discovery: Future-Ready Strategies is a comprehensive course designed to empower learners with essential skills for success in the evolving pharmaceutical industry. This certificate program highlights the latest trends, technologies, and strategies in drug discovery, fostering a deep understanding of the entire process from target identification to clinical trials.
6,309+
Students enrolled
GBP £ 149
GBP £ 215
Save 44% with our special offer
ๅ ณไบ่ฟ้จ่ฏพ็จ
100%ๅจ็บฟ
้ๆถ้ๅฐๅญฆไน
ๅฏๅไบซ็่ฏไนฆ
ๆทปๅ ๅฐๆจ็LinkedInไธชไบบ่ตๆ
2ไธชๆๅฎๆ
ๆฏๅจ2-3ๅฐๆถ
้ๆถๅผๅง
ๆ ็ญๅพ ๆ
่ฏพ็จ่ฏฆๆ
โข Drug Discovery Fundamentals: An introduction to drug discovery, including historical context, current trends, and future directions. This unit will cover the basic principles of drug discovery, from target identification to preclinical and clinical development.
โข Target Identification and Validation: This unit will focus on the initial stages of drug discovery, including target identification, validation, and selection. It will cover various approaches for target identification, such as genomics, proteomics, and bioinformatics, as well as methods for validating targets, such as in vitro and in vivo assays.
โข Hit Finding and Lead Optimization: This unit will cover the process of identifying hit compounds and optimizing them for further development. It will discuss various high-throughput screening techniques, including biochemical, biophysical, and cell-based assays, as well as medicinal chemistry approaches for lead optimization.
โข Drug Metabolism and Pharmacokinetics (DMPK): This unit will focus on the absorption, distribution, metabolism, and excretion (ADME) of drugs, including the impact of DMPK on drug safety and efficacy. It will cover various in vitro and in vivo models for predicting drug disposition and pharmacokinetics, as well as strategies for optimizing drug properties.
โข Preclinical Development and Safety Assessment: This unit will cover the preclinical development of drugs, including safety assessment, toxicity testing, and regulatory requirements. It will discuss various in vitro and in vivo models for predicting drug safety, as well as strategies for mitigating risks and ensuring regulatory compliance.
โข Clinical Development and Translation: This unit will focus on the clinical development of drugs, including study design, clinical trial execution, and regulatory approval. It will cover various clinical trial phases, including Phase 1, 2, and 3 trials, as well as strategies for translating preclinical findings into clinical applications.
โข Artificial Intelligence (AI) and Machine Learning (ML
่ไธ้่ทฏ
ๅ ฅๅญฆ่ฆๆฑ
- ๅฏนไธป้ข็ๅบๆฌ็่งฃ
- ่ฑ่ฏญ่ฏญ่จ่ฝๅ
- ่ฎก็ฎๆบๅไบ่็ฝ่ฎฟ้ฎ
- ๅบๆฌ่ฎก็ฎๆบๆ่ฝ
- ๅฎๆ่ฏพ็จ็ๅฅ็ฎ็ฒพ็ฅ
ๆ ้ไบๅ ็ๆญฃๅผ่ตๆ ผใ่ฏพ็จ่ฎพ่ฎกๆณจ้ๅฏ่ฎฟ้ฎๆงใ
่ฏพ็จ็ถๆ
ๆฌ่ฏพ็จไธบ่ไธๅๅฑๆไพๅฎ็จ็็ฅ่ฏๅๆ่ฝใๅฎๆฏ๏ผ
- ๆช็ป่ฎคๅฏๆบๆ่ฎค่ฏ
- ๆช็ปๆๆๆบๆ็็ฎก
- ๅฏนๆญฃๅผ่ตๆ ผ็่กฅๅ
ๆๅๅฎๆ่ฏพ็จๅ๏ผๆจๅฐ่ทๅพ็ปไธ่ฏไนฆใ
ไธบไปไนไบบไปฌ้ๆฉๆไปฌไฝไธบ่ไธๅๅฑ
ๆญฃๅจๅ ่ฝฝ่ฏ่ฎบ...
ๅธธ่ง้ฎ้ข
่ฏพ็จ่ดน็จ
- ๆฏๅจ3-4ๅฐๆถ
- ๆๅ่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๆฏๅจ2-3ๅฐๆถ
- ๅธธ่ง่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๅฎๆด่ฏพ็จ่ฎฟ้ฎ
- ๆฐๅญ่ฏไนฆ
- ่ฏพ็จๆๆ
่ทๅ่ฏพ็จไฟกๆฏ
่ทๅพ่ไธ่ฏไนฆ
